| 000 | 01970cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030933.0 | ||
| 008 | 140212s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.28.Ph.D.2013.Ma.S | ||
| 100 | 0 | _aMai Saad Eldin Mahmoud Badr | |
| 245 | 1 | 0 |
_aStudy of 1,25 dihydroxycholecalciferol and its relation to bone mineral density and heart disease in Egyptian beta thalessmia patients/ _cMai Saad Eldin Mahmoud Badr ; Supervised Mona Hassan Eltagui , Mona Mohamed Hamdy , Naglaa Mohamed Abdelrazek |
| 246 | 1 | 5 | _aدراسة ١:٢٥ دايهيدروكسى فيتامين د وعلاقته بكاثافة العظام وامراض القلب لدى المرضى المصابين بانيميا البحر المتوسط |
| 260 |
_aCairo : _bMai Saad Eldin Mahmoud Badr , _c2013 |
||
| 300 |
_a154 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine- Department of Pediatrics | ||
| 520 | _aThe aim of this study was to assess the levels of serum 1,25 dihydroxycholecalciferol and its relation to bone mineral density and heart disease in beta thalessmia patients. Methods: Eighty patients with B-thalassemia major with a mean age 16 years (range 10 - 22years), underwent full history taking, clinical examination and laboratory tests including complete blood count, calcium,phosphorus, alkaline phosphatase, serum ferritin and serum 1,25 dihydroxycholecalciferol | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _a1,25 dihydroxy cholecalciferol | |
| 653 | 4 | _aDXA | |
| 653 | 4 | _aThalessmia major | |
| 700 | 0 |
_aMona Hassan Eltagui , _eSupervisor |
|
| 700 | 0 |
_aMona Mohamed Hamdy , _eSupervisor |
|
| 700 | 0 |
_aNaglaa Mohamed Abdelrazek , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAml _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c45091 _d45091 |
||